Amneal’s long-acting Parkinson’s drug gets cold shoulder from FDA

Amneal’s long-acting Parkinson’s drug gets cold shoulder from FDA

Submitted by admin on July 5, 2023 - 7:03pm
Source: 
Medical Marketing and Media
News Tags: 
Amneal Pharmaceuticals
FDA
Parkinson's Disease
IPX203
Headline: 
Amneal’s long-acting Parkinson’s drug gets cold shoulder from FDA
snippet: 

The Food and Drug Administration issued a rejection of extended-release Parkinson’s disease pill IPX203, drugmaker Amneal Pharmaceuticals said this week. 

Do Not Allow Advertisers to Use My Personal information